[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100489090":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":23,"locations":29,"responsibleParty":128,"collaborators":22,"id":130,"slug":131,"hasResults":132,"nctId":133,"briefTitle":134,"officialTitle":135,"acronym":22,"eligibilityCriteria":136,"healthyVolunteers":132,"sex":137,"minAge":138,"maxAge":139,"enrollmentInfo":140,"targetDuration":22,"studyType":143,"phases":144,"briefSummary":146,"conditions":147,"keywords":150,"overallStatus":32,"whyStopped":22,"lastUpdateSubmitDate":152,"lastUpdatePostDateStruct":153,"startDateStruct":156,"completionDateStruct":158,"leadSponsor":160,"locationsCount":161},{"fullName":5,"class":6},"Vanda Pharmaceuticals","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Iloperidone","EXPERIMENTAL","Open-label iloperidone",[13],"Drug: Iloperidone",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","oral tablet",[9],[20,21],"VYV-683","FANAPT",null,[24],{"name":25,"role":26,"phone":27,"phoneExt":22,"email":28},"Vanda Pharmaceuticals Inc.","CONTACT","202-734-3400","clinicaltrials@vandapharma.com",[30,46,57,68,75,85,96,106,117],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Vanda Investigational Site","RECRUITING","Little Rock","Arkansas","72204","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-92.28959,34.74648,{"lat":42,"lon":41},[45],{"name":22,"role":26,"phone":27,"phoneExt":22,"email":22},{"facility":31,"status":32,"city":47,"state":48,"zip":49,"country":36,"countryCode":37,"cosmosGeoPoint":50,"geoPoint":54,"contacts":55},"Denver","Colorado","80202",{"type":39,"coordinates":51},[52,53],-104.9847,39.73915,{"lat":53,"lon":52},[56],{"name":22,"role":26,"phone":27,"phoneExt":22,"email":22},{"facility":31,"status":32,"city":58,"state":59,"zip":60,"country":36,"countryCode":37,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"Atlanta","Georgia","30318",{"type":39,"coordinates":62},[63,64],-84.38798,33.749,{"lat":64,"lon":63},[67],{"name":22,"role":26,"phone":27,"phoneExt":22,"email":22},{"facility":31,"status":32,"city":58,"state":59,"zip":69,"country":36,"countryCode":37,"cosmosGeoPoint":70,"geoPoint":72,"contacts":73},"30331",{"type":39,"coordinates":71},[63,64],{"lat":64,"lon":63},[74],{"name":22,"role":26,"phone":27,"phoneExt":22,"email":22},{"facility":31,"status":32,"city":76,"state":59,"zip":77,"country":36,"countryCode":37,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"Decatur","30030",{"type":39,"coordinates":79},[80,81],-84.29631,33.77483,{"lat":81,"lon":80},[84],{"name":22,"role":26,"phone":27,"phoneExt":22,"email":22},{"facility":31,"status":32,"city":86,"state":87,"zip":88,"country":36,"countryCode":37,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"Cincinnati","Ohio","45221",{"type":39,"coordinates":90},[91,92],-84.51439,39.12711,{"lat":92,"lon":91},[95],{"name":5,"role":26,"phone":27,"phoneExt":22,"email":22},{"facility":31,"status":32,"city":97,"state":87,"zip":98,"country":36,"countryCode":37,"cosmosGeoPoint":99,"geoPoint":103,"contacts":104},"Garfield Heights","44125",{"type":39,"coordinates":100},[101,102],-81.60596,41.417,{"lat":102,"lon":101},[105],{"name":22,"role":26,"phone":27,"phoneExt":22,"email":22},{"facility":31,"status":107,"city":108,"state":87,"zip":109,"country":36,"countryCode":37,"cosmosGeoPoint":110,"geoPoint":114,"contacts":115},"NOT_YET_RECRUITING","Westlake","44145",{"type":39,"coordinates":111},[112,113],-81.91792,41.45532,{"lat":113,"lon":112},[116],{"name":22,"role":26,"phone":27,"phoneExt":22,"email":22},{"facility":31,"status":32,"city":118,"state":119,"zip":120,"country":36,"countryCode":37,"cosmosGeoPoint":121,"geoPoint":125,"contacts":126},"Everett","Washington","98201",{"type":39,"coordinates":122},[123,124],-122.20208,47.97898,{"lat":124,"lon":123},[127],{"name":22,"role":26,"phone":27,"phoneExt":22,"email":22},{"type":129,"investigatorFullName":22,"investigatorTitle":22,"investigatorAffiliation":22,"oldNameTitle":22,"oldOrganization":22},"SPONSOR","100489090","phase-4-safety-and-tolerability-of-open-labeled-iloperidone-in-adolescents-100489090",false,"NCT05648591","Safety and Tolerability of Open-Labeled Iloperidone in Adolescents","Open-label Safety Study of a 1-year 8 to 24 mg\u002FDay Dose Regimen of Iloperidone (FANAPT®) in Adolescent Patients With Schizophrenia or Bipolar I Disorder","Inclusion Criteria:\n\n* Patient is willing and able to provide assent and willing to complete all aspects of the study\n* Patient's parent or legal guardian willing and able to provide consent\n* Male or female patients 12 through 17 years of age (inclusive)\n* Clinical diagnosis of either schizophrenia or bipolar I disorder\n\nExclusion Criteria:\n\n* Use of other investigational drugs at the time of enrollment, or within 30 days or 5 half-lives of enrollment, whichever is longer\n* A positive test for drugs of abuse","ALL","12 Years","17 Years",{"count":141,"type":142},100,"ESTIMATED","INTERVENTIONAL",[145],"PHASE4","To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.",[148,149],"Schizophrenia","Bipolar I Disorder",[151],"fanapt","2025-02-27",{"date":154,"type":155},"2025-03-04","ACTUAL",{"date":157,"type":155},"2023-05-24",{"date":159,"type":142},"2026-11-30",{"name":5,"class":6},9]